Sage Journals: Discover world-class research

Free access

Review article

First published 2017-8

Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions

Aurélien Lambert, Céline Gavoille, Thierry Conroy

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2020

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma

Changhoon Yoo, Inhwan Hwang, Tae Jun Song [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2020

Systematic review and meta-analysis of gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer

Victor H. F. de Jesus, Marcos P. G. Camandaroba, Vinicius F. Calsavara [...]

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2020-10

Steatohepatitis due to FOLFIRINOX regimen in adjuvant pancreas cancer treatment mimicking liver metastasis

Berna Bozkurt Duman, Timuçin Çil

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2021

Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX

Fleur van der Sijde, Zakia Azmani, Marc G. Besselink [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2023

Real-world dose reduction of standard and modified FOLFIRINOX in metastatic pancreatic cancer: a systematic review,evidence-mapping,and meta-analysis

Kwangrok Jung, Suhyun Choi, Hyunjoo Song [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Prognostic value of the TP53 mutation in patients with pancreatic ductal adenocarcinoma receiving FOLFIRINOX

Min Kyu Kim, In Rae Cho, Yooeun Kim [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022-4

Efficacy and safety of FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy: A systematic review and meta-analysis

Wenjie Lu, Lantian Wang, Xiawei Li [...]

Journal of International Medical Research

Open access

Research article

First published 2021

FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma

Antonin Vary, Loïc Lebellec, Frédéric Di Fiore [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2020

FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules

Francesca Foschini, Fabiana Napolitano, Alberto Servetto [...]

Therapeutic Advances in Medical Oncology

Search results